Skip to main content

Headlines

Axsome Therapeutics' Phase 3 SYMPHONY Study In Narcolepsy Meets Primary Goal
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Is Viking Therapeutics Stock a Millionaire Maker?
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Where Will Viking Therapeutics Stock Be in 10 Years?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Commit To Purchase Verve Therapeutics At $10, Earn 22.4% Annualized Using Options
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Zacks Investment Ideas feature highlights: Apple, Alphabet, Eli Lilly, Novo Nordisk and Viking Therapeutics
posted:
by: Nasdaq AAPL Apple
#channels:: #All, #Business, #Nasdaq, #Technology, #Stocks, #AAPL, #Apple
Time to be "Overweight" Viking Therapeutics
posted:
by: Nasdaq AAPL Apple
#channels:: #All, #Business, #Nasdaq, #Technology, #Stocks, #AAPL, #Apple
PTC Therapeutics Submits BLA To FDA For Upstaza - Quick Facts
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Is It Too Late to Buy CRISPR Therapeutics Stock?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Will Viking Therapeutics Get Acquired?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Cognition Therapeutics Prices Public Offering Of About 6.57 Mln Shares At $1.75/shr
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Calliditas Therapeutics Receives Seven More Years Of Market Exclusivity For Nefecon In U.S.
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META